"10.1371_journal.pone.0120657","plos one","2015-03-20T00:00:00Z","Steeve Provencher; Patrap Paruchuru; Andrea Spezzi; Brian Waterhouse; Mardi Gomberg-Maitland; on behalf of the pH12 Flolan reformulation study group","Pulmonary Hypertension Research Group, Centre de recherche de l’Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Québec, Canada; GlaxoSmithKline R&D, 980 Great West Road, Brentford, United Kingdom; University of Chicago Medical Centre, 5841 S Maryland Ave, MC5403, Rm L08, Chicago, Illinois, United States of America","Conceived and designed the experiments: SP PP AS BW MGM. Performed the experiments: SP PP AS BW MGM. Analyzed the data: SP PP AS BW MGM. Contributed reagents/materials/analysis tools: SP PP AS BW MGM. Wrote the paper: SP PP AS BW MGM.","SP is a research scholar of the Fonds de Recherche en Santé du Québec and as received speaker fees from Actelion, consultant fees from Actelion, Bayer, Merck and Pfizer, and research grant from Actelion, Bayer and Glaxo Smith Kline. PP, AS and BW are employed by Glaxo Smith Kline. MGM has no conflict of interest to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","03","Steeve Provencher","SP",6,TRUE,5,5,5,5,TRUE,TRUE,TRUE,1,"6",TRUE
